MX2013000003A - Dispositivos intravaginales que comprenden agentes anticolinergicos y metodos para prepararlos. - Google Patents

Dispositivos intravaginales que comprenden agentes anticolinergicos y metodos para prepararlos.

Info

Publication number
MX2013000003A
MX2013000003A MX2013000003A MX2013000003A MX2013000003A MX 2013000003 A MX2013000003 A MX 2013000003A MX 2013000003 A MX2013000003 A MX 2013000003A MX 2013000003 A MX2013000003 A MX 2013000003A MX 2013000003 A MX2013000003 A MX 2013000003A
Authority
MX
Mexico
Prior art keywords
pocket
matrix
making
methods
anticholinergic agents
Prior art date
Application number
MX2013000003A
Other languages
English (en)
Inventor
Anu Mahashabde
Jiaxiang Tsao
Original Assignee
Teva Womens Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Womens Health Inc filed Critical Teva Womens Health Inc
Publication of MX2013000003A publication Critical patent/MX2013000003A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/48Devices for preventing wetting or pollution of the bed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Environmental & Geological Engineering (AREA)
  • Cardiology (AREA)
  • Nursing (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Casting Or Compression Moulding Of Plastics Or The Like (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a un dispositivo intravaginal que comprende: (a) una primera matriz anular que comprende una cavidad y una pared de cavidad, en donde la pared de la cavidad tiene un espesor uniforme, y en donde la pared de la cavidad abarca la cavidad; y (b) una segunda matriz que comprende un agente anticolinérgico, en donde la segunda matriz está ubicada en la cavidad. La presente invención también se refiere a un método de preparación de un dispositivo intravaginal, que comprende: (a) ubicar la primera matriz en un molde, donde el molde tiene una forma tal para formar un dispositivo intravaginal anular que comprende una cavidad y una pared de la cavidad, en donde la pared de la cavidad tiene un espesor uniforme, y en donde la pared de la cavidad abarca la cavidad; (b) curar la primera matriz; (c) ubicar una segunda matriz que comprende un agente anticolinérgico en la cavidad; y (d) curar la segunda matriz.
MX2013000003A 2010-06-22 2011-06-22 Dispositivos intravaginales que comprenden agentes anticolinergicos y metodos para prepararlos. MX2013000003A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35732510P 2010-06-22 2010-06-22
PCT/US2011/041447 WO2011163358A2 (en) 2010-06-22 2011-06-22 Intravaginal devices comprising anticholinergic agents, and methods of making thereof

Publications (1)

Publication Number Publication Date
MX2013000003A true MX2013000003A (es) 2013-04-29

Family

ID=45372076

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013000003A MX2013000003A (es) 2010-06-22 2011-06-22 Dispositivos intravaginales que comprenden agentes anticolinergicos y metodos para prepararlos.

Country Status (15)

Country Link
US (1) US20120053534A1 (es)
EP (1) EP2585011A4 (es)
JP (1) JP2013535992A (es)
KR (1) KR20130045332A (es)
CN (1) CN103179926A (es)
AR (1) AR088410A1 (es)
AU (1) AU2011270997A1 (es)
BR (1) BR112012032951A2 (es)
CA (1) CA2803874A1 (es)
EA (1) EA201291298A1 (es)
MX (1) MX2013000003A (es)
PE (1) PE20130659A1 (es)
SG (2) SG186814A1 (es)
TW (1) TW201212939A (es)
WO (1) WO2011163358A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019201713A1 (en) 2018-04-10 2019-10-24 Ligalli B.V. Vaginal systemic drug delivery
EP3820356A4 (en) * 2018-07-12 2022-06-08 Richter Gedeon Nyrt. DEVICE AND METHOD FOR VAGINAL TEMPERATURE DETECTION

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920805A (en) * 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US5034189A (en) * 1985-08-27 1991-07-23 The Regents Of The University Of California Fluorescent probe for rapid measurement of analyte concentration
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
ATE313422T1 (de) * 1998-05-01 2006-01-15 Duramed Pharmaceuticals Inc Verfahren zur spritzgussherstellung von vorrichtungen mit kontrollierter wirkstofffreisetzung und damit hergestellte vorrichtung
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
WO2001085132A1 (en) * 2000-05-10 2001-11-15 Leiras Oy Drug delivery device, especially for the delivery of levonorgestrel
US7005138B2 (en) * 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
EP1620060B1 (en) * 2003-04-29 2010-03-24 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
CN1822815B (zh) * 2003-07-10 2012-04-11 沃纳奇尔科特(爱尔兰)有限公司 阴道内药物传递装置
US7425340B2 (en) * 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
CA2596933A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Devices for delivering agents to a vaginal tract
WO2007021964A2 (en) * 2005-08-11 2007-02-22 Massachusetts Institute Of Technology Intravesical drug delivery device and method
JP5312027B2 (ja) * 2005-09-02 2013-10-09 セラヴィダ、インク 病気の治療法
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
KR20100133969A (ko) * 2008-02-04 2010-12-22 테바 위민즈 헬스 인코포레이티드 프로게스테론 함유 단일형 질내 링 및 그의 제조방법과 용도
EP2106792A1 (en) * 2008-04-02 2009-10-07 Pelvipharm Use of a combination of udenafil and alfuzosin or oxybutynin for the treatment of overactive bladder
US20100040671A1 (en) * 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof

Also Published As

Publication number Publication date
EP2585011A4 (en) 2014-10-15
BR112012032951A2 (pt) 2018-02-27
PE20130659A1 (es) 2013-06-15
TW201212939A (en) 2012-04-01
SG10201504864UA (en) 2015-07-30
WO2011163358A2 (en) 2011-12-29
SG186814A1 (en) 2013-02-28
US20120053534A1 (en) 2012-03-01
WO2011163358A3 (en) 2012-03-01
CN103179926A (zh) 2013-06-26
JP2013535992A (ja) 2013-09-19
AU2011270997A1 (en) 2013-01-10
EA201291298A1 (ru) 2013-09-30
EP2585011A2 (en) 2013-05-01
AR088410A1 (es) 2014-06-11
CA2803874A1 (en) 2011-12-29
KR20130045332A (ko) 2013-05-03

Similar Documents

Publication Publication Date Title
HK1162872A1 (en) Mold set, compressive device and dumpling forming machine
MX2012015187A (es) Metodo para suministrar un agente activo.
IN2015DN02784A (es)
MY150626A (en) Fast dissolving solid dosage form
GB2508777A (en) Polymeric material for an insulated container
WO2010101744A3 (en) Tool sleeve for mold die and method of molding parts using the same
UA111972C2 (uk) Вагінальна таблетка, яка містить рифаксимін, спосіб її виготовлення та застосування для лікування вагінальних інфекцій
NZ601645A (en) Methods for improving sperm functionality comprising a pegylated binding agent
MY191875A (en) Solid dosage form
EA201201151A1 (ru) Эффективный по энергетическим и весовым показателям стеновой блок, способ производства и применение стенового блока
PH12014501240A1 (en) Film containing compositions
PH12015501187A1 (en) Method for synchronizing time of insemination in gilts
MX2014001775A (es) Mejora de recubrimiento semi-permanente de una herramienta para aumentar el numero de liberaciones.
MX2013000003A (es) Dispositivos intravaginales que comprenden agentes anticolinergicos y metodos para prepararlos.
EP2605795A4 (en) INTRAVAGINAL DEVICES AND METHOD FOR THEIR MANUFACTURE AND USE
WO2011163356A3 (en) Methods of treating conditions associated with overactive bladder
UA105375C2 (uk) Спосіб виготовлення вагінального супозиторія
WO2013023756A9 (de) Verfahren zur überprüfung eines gegenstands mit materialfreien bereichen
EP2799043A4 (en) VAGINAL RING WITH MELOXICAM AND A MEANS FOR MODULATING THE RELEASE OF AN ACTIVE AGGREGATE FOR USE AS A CONTINUOUS RECIPIENT OF PREVENTION IN WOMEN
MY170676A (en) Settable compositions comprising cement kiln dust and rice husk ash and methods of use
SG2013042809A (en) Backfill grout a-liquid, backfill grout, methods of making and use thereof
UA41936U (ru) Способ лечения крауроза вульвы в детском возрасте
UA62540U (ru) Способ лечения влагалищного кандидоза
MY197131A (en) Fast dissolving solid dosage form
PL400023A1 (pl) Narzedzie do wytwarzania wyprasek o ksztaltach obrotowych, z materialu proszkowego, prasowanego izostatycznie na zimno

Legal Events

Date Code Title Description
FA Abandonment or withdrawal